Study tests atezolizumab plus chemotherapy in advanced urothelial cancer after progression on PD-1 or PD-L1 therapy
Indiana University Melvin and Bren Simon Cancer Center is leading a phase II clinical trial that will test the PD-L1 checkpoint inhibitor atezolizumab plus chemotherapy […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter